Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experience - 09/08/11

Doi : 10.1016/j.jaad.2005.12.030

Pedro C. Queiroz Zancanaro, MD ^a,^{^{These authors contributed equally to this manuscript.}}, Laura Y. McGirt, MD ^b,^{^{These authors contributed equally to this manuscript.}}, Adam J. Mamelak, MD ^b, Ruby H.-N. Nguyen, PhD ^c, Ciro R. Martins, MD ^b,^⁎
^a From the Faculdade de Medicina, Universidade de Brasilia
^b Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore
^c The National Institute of Environmental Health Sciences, Durham

Reprint requests: Ciro R. Martins, MD, Department of Dermatology, Johns Hopkins University, 550 N Broadway, Suite 1002, Baltimore, MD 21205.

Brasilia, Brazil, Baltimore, Maryland, and Durham, North Carolina

Abstract

Background

Widespread introduction of highly active antiretroviral therapy (HAART) in the mid 1990s has altered the presentation of the cutaneous manifestations associated with HIV infection.

Objective

Our purpose was to evaluate the use of HAART on the prevalence and spectrum of cutaneous manifestations in HIV-infected patients.

Methods

A study of the initial visits of 897 HIV-infected patients at an urban dermatology clinic between 1996 and 2002 was performed.

Results

Folliculitis was the most common cutaneous disorder identified. Patients with CD4-positive cell counts less than 200 cells/mm³ had an increased prevalence of folliculitis and prurigo nodularis, whereas those with HIV viral loads higher than 55,000 copies/mL had a higher prevalence of idiopathic pruritus and candidiasis. Patients not receiving HAART had increased rates of folliculitis and prurigo nodularis. Patients receiving HAART had increased rates of photosensitivity and molluscum contagiosum.